Medical AI startup Boltz raises $110M to speed up small molecule research

Boltz PBC, a startup that develops artificial intelligence models for pharmaceutical researchers, has raised $110 million in funding. Bessemer led the Series A investment. Boltz stated on Wednesday that the fund was joined by a large group of new and returning backers. The consortium included Greycroft, Andreessen Horowitz, Amplify Partners, F-Prime Capital, Hummingbird and others. […]

This article has been indexed from AI – SiliconANGLE